Glioblastoma multiforme stem cells

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 930-958

  Dimov, Irena ^a   Tasić Dimov, Desanka ^a   Conić, Irena ^a   Stefanovic, Vladisav ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

Epigenetics; Glioblastoma multiforme; Immunosuppression; Markers; Therapy; Tumor stem cell

Indexed keywords

CD133 ANTIGEN; CD15 ANTIGEN; CD44V ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GANGLIOSIDE; INTERLEUKIN 10; MICRORNA; MUSASHI 1; NESTIN; NOTCH RECEPTOR; PROGRAMMED DEATH 1 LIGAND 1; PROSTAGLANDIN E2; PROTEIN TYROSINE KINASE; RNA BINDING PROTEIN; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ALLERGY; CANCER IMMUNOTHERAPY; CANCER STEM CELL; CENTRAL NERVOUS SYSTEM TUMOR; EPIGENETICS; GLIOBLASTOMA; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MICROGLIA; NONHUMAN; PREDICTION; REGULATORY T LYMPHOCYTE; REVIEW; SIDE POPULATION CELL; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ANIMALS; BIOLOGICAL MARKERS; EPIGENESIS, GENETIC; GLIOBLASTOMA; HUMANS; IMMUNOSUPPRESSION; MICE; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 79958175730     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.42     Document Type: Review

References (253)

1. Hayden, E.C. (2010) Genomics boosts brain-cancer work. Nature 463(7279), 278.
2. Kuehn, B.M. (2010) Genomics illuminates a deadly brain cancer. JAMA 303(10), 925-927.
3. Ohgaki, H. and Kleihues P. (2009) Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci. 100(12), 2235.
4. Singh, S.K., Clarke, I.D., Terasaki, M., Bonn, V.E., Hawkins, C., Squire, J., and Dirks, P.B. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828. (Pubitemid 37187480)
5. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman R.M., Cusimano M.D., and Dirks, P.B. (2004) Identification of human brain tumour initiating cells. Nature 432, 396-401. (Pubitemid 39551674)
6. Sanai, N., Alvarez-Buylla, A., and Berger, M.S. (2005) Neural stem cells and the origin of gliomas. N. Engl. J. Med. 353, 811-822.
7. Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., and Vescovi, A. (2004) Isolation and characterization of tumourigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011-7021. (Pubitemid 39331011)
8. Bao, S., Wu, Q., McLendon, R.E., et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760. (Pubitemid 44949604)
9. Eramo, A., Ricci-Vitiani, L., Zeuner, A., et al. (2006) Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 13, 1238-1241. (Pubitemid 43905604)
10. Garcia, A.D., Doan, N.B., Imura, T., Bush, T.G., and Sofroniew, M.V. (2004). GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 7, 1233-1241. (Pubitemid 39426243)
11. Ramirez-Castillejo, C., Sanchez-Sanchez, F., Andreu-Agullo, C., Ferron, S.R., Aroca-Aguilar, J.D., Sanchez, P., Mira, H., Escribano, J., and Farinas, I. (2006). Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat. Neurosci. 9, 331-339. (Pubitemid 43290962)
12. Shen, Q., Goderie, S.K., Jin, L., Karanth, N., Sun, Y., Abramova, N., Vincent, P., Pumiglia, K., and Temple, S. (2004). Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338-1340. (Pubitemid 38697433)
13. Tavazoie, M., Van der Veken, L., Silva-Vargas, V., Louissaint, M., Colonna, L., Zaidi, B., Garcia-Verdugo, J.M., and Doetsch F. (2008) A specialized vascular niche for adult neural stem cells cell stem cell. Trends Mol. Med. 3, 279-288.
14. Martino, G. and Pluchino, S. (2006). The therapeutic potential of neural stem cells. Nat. Rev. Neurosci. 7, 395-406.
15. Li, L. and Neaves, W.B. (2006) Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 66(9), 4553-4557.
16. Calabrese, C., Poppleton, H., Kocak, M., Hogg, T.L., Fuller, C., Hamner, B.,Oh, E.Y., Gaber, W., Finklestein, D., Allen, M, Frank, A., Bayazitov, I.T., Zakharenko, S.S., Gajjar, A., Davidoff, A., and Gilbertson, R.J. (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11, 69-82. (Pubitemid 46054518)
17. Carson, M.J., Doose, J.M., Melchior, B., Schmid, C.D., and Ploix, C.C. (2006). CNS immune privilege: hiding in plain sight. Immunol. Rev. 213, 48-65. (Pubitemid 44401493)
18. Mendez-Fernandez, Y.V., Hansen, M.J., Rodriguez, M., and Pease, L.R. (2005) Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler's virus infection. J. Virol. 79, 3063-3070. (Pubitemid 40270585)
19. Hatterer, E., Davoust, N., Didier-Bazes, M., Vuaillat, C., Malcus, C., Belin, M.-F., and Nataf, S. (2006). How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes. Blood 107, 806-812. (Pubitemid 43076409)
20. Parney, I.F., Chang, L.-J., Farr-Jones, M.A., Hao, C., Smylie, M., and Petruk, K.C. (2006) Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas. J. Neurooncol. 78(1), 71-80. (Pubitemid 43786663)
21. Parajuli, P. and Sloan, A.E. (2004) Dendritic cell-based immunotherapy of malignant gliomas. Cancer Invest. 22(3), 405-416. (Pubitemid 39310911)
22. Holland, E.C. (2000) Glioblastoma multiforme: the terminator. Proc. Natl. Acad. Sci. U. S. A. 97(12), 6242-6244.
23. Ignatova, T.N., Kukekov, V.G., Laywell, E.D., Suslov, O.N., Vrionis, F.D., and Steindler, D.A. (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39, 193-206.
24. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N.M., Pastorino, S., Purow, B.W., Christopher, N., Zhang, W., et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403. (Pubitemid 43668737)
25. Ghods, A.J., Irvin, D., Liu, G., Yuan, X., Abdulkadir, I.R., Tunici, P., Konda, B., Wachsmann-Hogiu, S., Black, K.L., and Yu, J.S. (2007) Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 25, 1645-1653. (Pubitemid 47121841)
26. Pellegatta, S., Poliani, P.L., Corno, D., Menghi, F., Ghielmetti, F., Suarez-Merino, B., Caldera, V., Nava, S., Ravanini, M., Facchetti, F., Bruzzone, M.G., and Finocchiaro, G. (2006) Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res. 66, 10247-10252. (Pubitemid 44799739)
27. Yuan, X., Curtin, J., Xiong, Y., Liu, G., Waschsmann-Hogiu, S., Farkas, D.L., Black, K.L., and Yu, J.S. (2004) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23, 9392-9400. (Pubitemid 40069671)
28. Bleau, A.-M., Howard, B.M., Taylor, L.A., Gursel, D.,Greenfield, J.P., Tung, H.Y.L., Holland, E.C., and Boockvar, J.A. (2008) New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurg. Focus 24(3&4), E27.
29. Gil-Perotin, S., Marin-Husstege, M., Li, J., Soriano-Navarro, M., Zindy, F., Roussel, M.F., Garcia-Verdugo, J.M., and Casaccia-Bonnefil, P. (2006) Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. J. Neurosci. 26, 1107-1116. (Pubitemid 43237042)
30. Cattaneo, E. and McKay, R. (1990) Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature 347, 762-765.
31. Messam, C.A., Hou, J., and Major, E.O. (2000) Coexpression of nestin in neural and glial cells in the developing human CNS defined by a human-specific anti-nestin antibody. Exp. Neurol. 161, 585-596. (Pubitemid 30137016)
32. Ehrmann, J., Kola'r, Z., and Mokry, J. (2005) Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours. J. Clin. Pathol. 58, 222-223. (Pubitemid 40193814)
33. Tamagno, I. and Schiffer, D. (2006) Nestin expression in reactive astrocytes of human pathology. J. Neurooncol. 80, 227-233. (Pubitemid 44782899)
34. Zhang, M., Song, T., Yang, L., Chen, R., Wu, L., Yang, Z., and Fang, J. (2008) Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J. Exp. Clin. Cancer Res. 27, 85.
35. Beier, D., Wischhusen, J., Dietmaier, W., Hau, P., Proescholdt, M., Brawanski, A., Bogdahn, U., and Beier, C.P. (2008) CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol. 18, 370-377. (Pubitemid 351782845)
36. Uchida, N., Buck, D.W., He, D., Reitsma, M.J., Masek, M., and Phan, T.V. (2000) Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. U. S. A. 97, 14720-14725. (Pubitemid 32016642)
37. Kania, G., Corbeil, D., and Fuchs, J. (2005) Somatic stem cell marker prominin-1/CD133 is expressed in embryonic stem cellderived progenitors. Stem Cells 23, 791-804. (Pubitemid 40791794)
38. Zeppernick, F., Ahmadi, R., Campos, B., et al. (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin. Cancer Res. 14, 123-129. (Pubitemid 351377986)
39. Pallini, R., Ricci-Vitiani, L., Banna, G.L., Signore, M., Lombardi, D., Matilde Todaro, M., Stassi, G., Martini, M., Maira, G., Larocca, L.M., and DeMaria, R. (2008) Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin. Cancer Res. 14(24), 8206-8212.
40. Wang, J., Sakariassen, P.O., Tsinkalovsky, O., Immervoll, H., Boe, S.O., Svendsen, A., Prestegarden, L., Rosland, G., Thorsen, F., Stuhr, L., Molven, A., Bjerkvig, R., et al. (2008) CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 122, 761-768.
41. Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P.J., Aigner, L., Brawanski, A., Bogdahn, U., and Beier, C.P. (2007) CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67, 4010-4015. (Pubitemid 46815044)
42. Ogden, A.T., Waziri, A.E., Lochhead, R.A., et al. (2008) Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery 62, 505-514. (Pubitemid 351489297)
43. Griguer, C.E., Oliva, C.R., Gobin, E., Marcorelles, P., Benos, D.J., Lancaster, J.R., and Gillespie, G.Y. (2008) CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3, e3655.
44. Kaneko, Y., Sakakibara, S., Imai, T., Suzuki, A., Nakamura, Y., Sawamoto, K., Ogawa, Y., Toyama, Y., Miyata, T., and Okano, H. (2000) Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev. Neurosci. 22, 139-153. (Pubitemid 30098914)
45. Okano, H., Imai, T., and Okabe, M. (2002) Musashi: a translational regulator of cell fate. J. Cell Sci. 115, 1355-1359. (Pubitemid 34428693)
46. Toda, M., Iizuka, Y., Yu, W., Imai, T., Ikeda, E., Yoshida, K., Kawase, T., Kawakami, Y., Okano, H., and Uyemura, K. (2001) Expression of the neural RNA-binding protein Musashi1 in human gliomas. Glia 43, 1-7. (Pubitemid 32329026)
47. Hemmati, H.D., Nakano, I., Lazareff, J.A., Masterman-Smith, M., Geschwind, D.H., Bronner-Fraser, M., and Kornblum, H.I. (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U. S. A. 100, 15178-15183. (Pubitemid 37518036)
48. Capela, A. and Temple, S. (2002) LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron 35, 865-875.
49. Coskun, V., Wu, H., Blanchi, B., Tsao, S., Kim, K., Zhao, J., Biancotti, J.C., Hutnick, L., Krueger, R.C., Fan, G., et al. (2008) CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc. Natl. Acad. Sci. U. S. A. 105, 1026-1031. (Pubitemid 351282075)
50. Read, T.A., Fogarty, M.P., Markant, S.L., McLendon, R.E., Wei, Z., Ellison, D.W., Febbo, P.G., and Wechsler-Reya, R.J. (2009) Identification of CD15 as a marker for tumorpropagating cells in a mouse model of medulloblastoma. Cancer Cell 15, 135-147.
51. Mao, X.-G., Zhang, X., Xue, X.-Y., Guo, G., Wang, P., Zhang, W., Fei, Z., Zhen, H.-N., You, S.-W., and Yang, H. (2009) Brain tumor stem-like cells identified by neural stem cell marker CD15. Transl. Oncol. 2, 247-257.
52. Ellis, P., Fagan, B.M., Magness, S.T., Hutton, S., Taranova, O., Hayashi, S., McMahon, A., Rao, M., and Pevny, L. (2004) SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev. Neurosci. 26(2-4), 148-165. (Pubitemid 40867972)
53. Ferri, A.L., Cavallaro, M., Braida, D., Di Cristofano, A., Canta, A., Vezzani, A., Ottolenghi, S., Pandolfi, P.P., Sala, M., DeBiasi, S., et al. (2004) Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development 131, 3805-3819. (Pubitemid 39199387)
54. Sisodiya, S.M., Ragge, N.K., Cavalleri, G.L., Hever, A., Lorenz, B., Schneider, A., Williamson, K.A., Stevens, J.M., Free, S.L., Thompson, P.J., et al. (2006) Role of SOX2 mutations in human hippocampal malformations and epilepsy. Epilepsia 47, 534-542. (Pubitemid 43351557)
55. Azuara, V., Perry, P., Sauer, S., Spivakov, M., Jorgensen, H.F., John, R.M., Gouti, M., Casanova, M., Warnes, G., Merkenschlager, M., et al. (2006) Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8, 532-538.
56. Lee, T.I., Jenner, R.G., Boyer, L.A., Guenther, M.G., Levine, S.S., Kumar, R.M., Chevalier, B., Johnstone, S.E., Cole, M.F., Isono, K., et al. (2006) Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125, 301-313. (Pubitemid 44313811)
57. Niwa, H., Miyazaki, J., and Smith, A. (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376. (Pubitemid 30187435)
58. Phi, J.H., Kim, J.H., Eun, K.M., Wang, K.C., Park, K.H., Choi, S.A., Kim, Y.Y., Park, S.H., Cho, B.K., and Kim, S.K. (2010) Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas. J. Neurosurg. Pediatr. 5(6), 608-614.
59. Phi, J.H., Park, S.H., Kim, S.K., Paek, S.H., Kim, J.H., Lee, Y.J., Cho, B.K., Park, C.K., Lee, D.H., and Wang, K.C. (2008) Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway. Am. J. Surg. Pathol. 32(1), 103-112.
60. Ehtesham, M., Mapara, K.Y., Stevenson, C.B., and Thompson, R.C. (2009) CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett. 274(2), 305-312.
61. Asensio, V.C. and Campbell, I.L. (1999) Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22, 504-512. (Pubitemid 29481851)
62. Lu, Q., Sun, E.E., Klein, R.S., and Flanagan, J.G. (2001) Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell 105, 69-79. (Pubitemid 32323917)
63. Zhu, Y., Yu, T., Zhang, X.C., Nagasawa, T., Wu, J.Y., and Rao, Y. (2002) Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat. Neurosci. 5, 719-720. (Pubitemid 34827584)
64. Zheng, H., Fu, G., Dai, T., and Huang, H. (2007) Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J. Cardiovasc. Pharmacol. 50(3), 274-280. (Pubitemid 47428975)
65. Balkwill, F. (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 14, 171-179.
66. Ehtesham, M., Winston, J.A., et al. (2006) CXCR4 expression mediates glioma cell invasiveness. Oncogene 25, 2801-2806.
67. Stevenson, C.B., Ehtesham, M., McMillan, K., Valadez, J.G., Edgeworth, M.L., Price, R.R., Abel, T.W., Mapara, K.Y., and Thompson, R.C. (2008) CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery 63(3), 560-570.
68. Khan, M.Z., Brandimarti, R., Brian Joseph Musser, B.J., Resue, D.M., Fatatis, A., and Meucci, O. (2003) The chemokine receptor CXCR4 regulates cell-cycle proteins in neurons. J. Neurovirol. 9(3), 300-314. (Pubitemid 36874706)
69. O'Hare, M.J., Hou, S.T., Morris, E.J., Cregan, S.P., Xu, Q., Slack, R.S., and Park, D.S. (2000) Induction and modulation of cerebellar granule neuron death by E2F-1. J. Biol. Chem. 275, 25358-25364.
70. Moroni, M.C., Hickman, E.S., Denchi, E.L., Caprara, G., Colli, E., Cecconi, F., Muller, H., and Helin, K. (2001) Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3, 552-558. (Pubitemid 32536851)
71. Salmaggi A, Boiardi A, Maurizio Gelati, M., Russo, A., Calatozzolo, C., Ciusani, E., Sciacca, F.L., Ottolina A., Parati, E.A., La Porta, C., Alessandri, G., Marras, C., Croci, D., and Rossi, M. (2006) Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54, 850-860. (Pubitemid 44671990)
72. Aghi, M., Cohen, K.S., Klein, R.J., Scadden, D.T., and Chiocca, E.A. (2006) Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res. 66, 9054-9064. (Pubitemid 44521124)
73. Rubin, J.B., Kung, A.L., Klein, R.S., Chan, J.A., Sun, Y., Schmidt, K., Kieran, M.W., Luster, A.D., and Segal, R.A. (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl. Acad. Sci. U. S. A. 100, 13513-13518. (Pubitemid 37444773)
74. Redjal, N., Chan, J.A., Segal, R.A., and Kung, A.L. (2006) CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin. Cancer Res. 12, 6765-6771. (Pubitemid 44876846)
75. Chan, K., Espinosa, I., Chao, M., Wong, D., Ailles, L., Diehn, M., Gill, H., Presti, J., Chang, H.Y., van de Rijn, M., Shortliffe, L., and Weissman, I.L. (2009) Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl. Acad. Sci. U. S. A. 106, 14016-14021.
76. Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J., and Maitland, N.J. (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946-10951. (Pubitemid 41713363)
77. Du, L., Wang, H., He, L., Zhang, J., Nil, B., Wang, X., Jin, H. Cahuzac, N., Mehrpour, M., Lu, Y., and Chen, Q. (2008) CD44 is of functional importance for colorectal cancer stem cells. Clin. Cancer Res. 14(21), 6751-6760.
78. Ariza, A., López, D., Mate, J., Isamat, M., Musulen, E., Pujol, M., Ley, A., and Navas-Palacios, J. (1995) Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study. Hum. Pathol. 26(10), 1144-1147.
79. Khoshyomn, S., Penar, P.L., Wadsworth, M.P., and Taatjes, D.J. (1997) Localization of CD44 at the invasive margin of glioblastomas by immunoelectron microscopy. Ultrastruct. Pathol. 21(6), 517-525. (Pubitemid 27486332)
80. Ranuncolo, S.M., Ladeda, V., Specterman, S., Varela, M., Lastiri, J, Morandi, A., Matos, E., Bal De Kier Joffe, E., Puricelli, L., and Pallotta, M.G. (2002) CD44 expression in human gliomas. J. Surg. Oncol. 79, 30-36.
81. Xu, Y., Stamenkovic, I., and Yu, Q. (2010) CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res. 70, 2455.
82. Wei, K.-C., Huang, C.-Y., Chen, P.-Y., Feng, L.-Y., Wu, T.-W.E., Chen, S.-M., Tsai, H.-C., Lu, Y.-J., Tsang, N.-M., Tseng, C.-K., Pai, P.-C., and Shin, J.-W. (2010) Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticanc. Res. 30(1), 253-259.
83. Wu, C., and Alman, B.A. (2008) Side population cells in human cancers. Cancer Lett. 268(1), 1-9.
84. Bunting, K.D. (2002) ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cell. 20(1), 11-20.
85. Borst, P. and Elferink, R.O. (2002) Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71, 537-592. (Pubitemid 34800230)
86. Moshaver, B., van Rhenen, A., Kelder, A., van der Pol, M., Terwijn, M., Bachas, C., Westra, A.H., Ossenkoppele, G.J., Zweegman, S., and Schuurhuis, G.J. (2008) Identification of a small subpopulation of candidate leukemiainitiating cells in the side population of patients with acute myeloid leukemia. Stem Cells 26, 3059-3067.
87. Engelmann, K., Shen, H., and Finn, O.J. (2008) MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res. 68, 2419-2426. (Pubitemid 351521817)
88. Hu, L., McArthur, C., and Jaffe, R.B. (2010) Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br. J.Cancer 102, 1276-1283.
89. Hirschmann-Jax, C., Foster, A.E., Wulf, G.G., Nuchtern, J.G., Jax, T.W., Gobel, U., Goodell, M.A., and Brenner, M.K. (2004) A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. U. S. A. 101(39), 14228-14233. (Pubitemid 39305058)
90. Harris, M.A., Yang, H., Low, B.E., Mukherje, J., Guha, A., Bronson, R.T., Shultz, L.D., Israel, M.A., and Yun, K. (2008) Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 68, 10051-10059.
91. Fukaya, R., Ohta, S., Yamaguchi, M., Fujii, H., Kawakami, Y., Kawase, T., and Toda, M. (2010) Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett. 291(2), 150-157.
92. Weber, K., Paulus, W., and Senner, V. (2010) The side population of gliomas exhibits decreased cell migration. J. Neuropathol. Exp. Neurol. 69(6), 623-631.
93. Broadley, K.W., Hunn, M.K., Farrand, K.J., Price, K.M., Grasso, C., Miller, R.J., Hermans, I.F., and McConnell, M.J. (2010) Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem Cells [Epub ahead of print]
94. Bachoo, R.M., Maher, E.A., Ligon, K.L., Sharpless, N.E., Chan, S.S., You, M.J., Tang, Y., DeFrances, J., Stover, E., Weissleder, R., Rowitch, D.H., Louis, D.N., and DePinho, R.A. (2002) Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1, 269-277. (Pubitemid 41039151)
95. Hambardzumyan, D., Squatrito, M., Carbajal, E., and Holland, E.C. (2008) Glioma formation, cancer stem cells, and akt signaling. Stem Cell Rev. 4, 203-210.
96. Fomchenko, E.I. and Holland, E.C. (2006) Mouse models of brain tumors and their applications in preclinical trials. Clin. Cancer Res. 12, 5288.
97. Li, L., Dutra, A., Pak, E., Labrie, J.E., Gerstein, R.M., Pandolfi, P.P., Recht, L.D., and Ross, A.H. (2009) EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol. 11, 9-21.
98. Soeda, A., Inagaki, A., Oka, N., Ikegame, Y., Aoki, H., Yoshimura, S.-I., Nakashima, S., Kunisada, T., and Iwama, T. (2008) Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J. Biol. Chem. 283, 10958-10966.
99. Beck, S., Jin, X., Sohn, Y.W., Kim, J.K., Kim, S.H., Yin, J., Pian, X., Kim, S.C., Nam, D.H., Choi, Y.J., and Kim, H. (2010) Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression. Mol. Cell [Epub ahead of print]
100. Kelly, J.J.P., Stechishin, O., Chojnacki, A., Lun, X., Sun, B., Senger, D.L., Forsyth, P., Auer, R.N., Dunn, J.F., Cairncross, J.G., Parney, I.F., and Weiss, S. (2009) Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells 27, 1722-1733.
101. Howard, B.M., Gursel, D.B., Bleau, A.M., Beyene, R.T., Holland, E.C., and Boockvar, J.A. (2010) EGFR signaling is differentially activated in patient-derived glioblastoma stem cells. J. Exp. Ther. Oncol. 8(3), 247-260.
102. Mazzoleni, S., Politi, L.S., Pala, M., Cominelli, M., Franzin, A., Sergi Sergi, L., Falini, A., De Palma, M., Bulfone, A., Poliani, P.L., and Galli, R. (2010) Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res. 70(19), 7500-7513.
103. Hu, X., Pandolfi, P.P., Li, Y., Koutcher, J.A., Rosenblum, M., and Holland, E.C. (2005) mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7(4), 356-368. (Pubitemid 40664225)
104. Endersby, R. and Baker, S.J. (2008) PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 27(41), 5416-5430.
105. Zheng, H., Ying, H., Yan, H., Kimmelman, A.C., Hiller, D.J., Chen, A.J., Perry, S.R., Tonon, G., Chu, G.C., Ding, Z., Stommel, J.M., Dunn, K.L., Wiedemeyer, R., You, M.J., Brennan, C., Wang, Y.A., Ligon, K.L., Wong, W.H., Chin, L., and DePinho, R.A. (2008) p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455(7216), 1129-1133.
106. Parsons, D.W., Jones, S., Zhang, X., Lin, J.C., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.M., Gallia, G.L., Olivi, A., McLendon, R., Rasheed, B.A., Keir, S., Nikolskaya, T., Nikolsky, Y., Busam, D.A., Tekleab, H., Diaz, L.A., Jr., Hartigan, J., Smith, D.R., Strausberg, R.L., Marie, S.K., Shinjo, S.M., Yan, H., Riggins, G.J., Bigner, D.D., Karchin, R., Papadopoulos, N., Parmigiani, G., Vogelstein, B., Velculescu, V.E., and Kinzler, K.W. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812.
107. Guha, A., Feldkamp, M.M., Lau, N., Boss, G., and Pawson, A. (1997) Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15(23), 2755-2765. (Pubitemid 28004565)
108. Rajasekhar, V.K., Viale, A., Socci, N.D., Wiedmann, M., Hu, X., and Holland, E.C. (2003) Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol. Cell 12(4), 889-901. (Pubitemid 37352782)
109. Holland, E.C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R.E., and Fuller, G.N. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25(1), 55-57. (Pubitemid 30257036)
110. Pelloski, C.E., Lin, E., Zhang, L., Yung, W.K., Colman, H., Liu, J.L., Woo, S.Y., Heimberger, A.B., Suki, D., Prados, M., Chang, S., Barker, F.G., 3rd, Fuller, G.N., and Aldape, K.D. (2006) Prognostic associations of activated mitogenactivated protein kinase and Akt pathways in glioblastoma. Clin. Cancer Res. 12(13), 3935-3941. (Pubitemid 44078078)
111. Eyler, C.E., Foo, W.C., LaFiura, K.M., McLendon, R.E., Hjelmeland, A.B., and Rich, J.N. (2008) Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 26, 3027-3036.
112. Gallia, G.L., Tyler, B.M., Hann, C.L., Siu, I.-M., Giranda, V.L., Vescovi, A.L., Brem, H., and Riggins, G.J. (2009) Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Mol. Cancer Ther. 8(2), 386-393.
113. Dahmane, N., Sánchez, P., Gitton, Y., Palma, V., Sun, T., Beyna, M., Weiner, H., and Ruiz i Altaba, A. (2001) The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 128(24), 5201-5212.
114. Clement. V., Sanchez, P., de Tribolet, N., Radovanovic, I., and Ruiz i Altaba, A. (2007) HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17(2), 165-172.
115. Zbinden, M., Duquet, A., Lorente-Trigos, A., Ngwabyt, S.N., Borges, I., and Ruiz i Altaba, A. (2010) NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J. 29(15), 2659-2674.
116. Bar, E.E., Chaudhry, A., Lin, A., Fan, X., Schreck, K., Matsui, W., Piccirillo, S., Vescovi, A.L., DiMeco, F., Olivi, A., and Eberhart, C.G. (2007) Cyclopamine-mediated Hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25, 2524-2533. (Pubitemid 47582744)
117. Gaiano, N. and Fishell, G. (2002) The role of Notch in promoting glial and neural stem cell fates. Annu. Rev. Neurosci. 25, 471-490. (Pubitemid 34748025)
118. Fan, X., Matsui, W., Khaki, L., Stearns, D., Chun, J., Li, Y.M., and Eberhart, C.G. (2006) Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66(15), 7445-7452. (Pubitemid 44289197)
119. Shih, A.H. and Holland, E.C. (2006) Notch signaling enhances nestin expression in gliomas. Neoplasia 8, 1072-1082. (Pubitemid 44936157)
120. Zhen, Y., Zhao, S., Li, Q., Li, Y., and Kawamoto, K. (2010) Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas. Cancer Lett. 292(1), 64-72.
121. Wang, J., Wakeman, T.P., Lathia, J.D., Hjelmeland, A.B., Wang, X.F., White, R.R., Rich, J.N., and Sullenger, B.A. (2010) Notch promotes radioresistance of glioma stem cells. Stem Cells 28(1), 17-28.
122. Charles, N., Ozawa, T., Squatrito, M., Bleau, A.-M., Brennan, C.W., Hambardzumyan, D., and Holland, E.C. (2010) Perivascular nitric oxide activates Notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6(2), 141-152.
123. Hovinga, K.E., Shimizu, F., Wang, R., Panagiotakos, G., Van Der Heijden, M., Moayedpardazi, H., Correia, A.S., Soulet, D., Major, T., Menon, J., and Tabar, V. (2010) Inhibition of Notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells 28(6), 1019-1029.
124. Cadieux, B., Ching, T.T., VandenBerg, S.R., and Costello, J.F. (2006) Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res. 66, 8469-8476. (Pubitemid 44449159)
125. Schmierer, B. and Hill, C.S. (2007) TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 8, 970-982. (Pubitemid 350174642)
126. Bruna, A., Darken, R.S., Rojo, F., Ocana, A., Penuelas, S., Arias, A., Paris, R., Tortosa, A., Mora, J., Baselga, J., and Seoane, J. (2007) High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11, 147-160. (Pubitemid 46209848)
127. Chen, H.L. and Panchinson, D.M. (2007) Concise review: bone morphogenic protein pleotropism in neural stem cells and their derivates - alternative pathways, convergent signals. Stem Cells 25, 63-68.
128. Lee, J., Son, M.J.,Woolard, K., Donin, N.M., Li, A., Cheng, C.H., Kotliarova, S., Kotliarov, Y., Walling, J., Ahn, S., Kim, M., Totonchy, M., Cusack, T., Ene, C., Ma, H., Su, Q., Zenklusen, J.C., Zhang, W., Maric, D., and Fine, H.A. (2008) Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13, 69-80. (Pubitemid 350309742)
129. Mohn, F., Weber, M., Rebhan, M., Roloff, T.C., Richter, J., Stadler, M.B., Bibel, M., and Schübeler, D. (2008) Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell 30(6), 755-766.
130. Bruggeman, S.W., Hulsman, D., Tanger, E., Buckle, T., Blom, M., Zevenhoven, J., van Tellingen, O., and van Lohuizen, M. (2007) Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 12(4), 328-341. (Pubitemid 47539307)
131. Abdouh, M., Facchino, S., Chatto, W., Balasingam, V., Ferreira, J., and Bernier, G. (2009) Bmi1 sustains human glioblastoma multiforme stem cell renewal. J. Neurosci. 29(28), 8884-8896.
132. Suvà, M.L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., Stehle, J.C., Baumer, K., Le Bitoux, M.A., Marino, D., Cironi, L., Marquez, V.E., Clément, V., and Stamenkovic, I. (2009) EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 69(24), 9211-9218.
133. Silber, J., Lim, D.A., Petritsch, C., Persson, A.I., Maunakea, A.K., Yu, M., Vandenberg, S.R., Ginzinger, D.G., James, C.D., Costello, J.F., Bergers, G., Weiss, W.A., Alvarez-Buylla, A., and Hodgson, J.G. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6, 14.
134. Gal, H., Pandi, G., Kanner, A.A., Ram, Z., Lithwick-Yanai, G., Amariglio, N., Rechavi, G., and Givol, D. (2008) MIR-451 and imatinib mesylate inhibit tumor growth of glioblastoma stem cells. Biochem. Biophys. Res. Commun. 376(1), 86-90.
135. Zhou, X., Ren, Y., Han, L., Mei, M., Xu, P., Zhang, C.-Z., Wang, G.-X., Jia, Z.-F., Pu, P.-Y., and Kang, C.-S. (2010) Role of the AKT pathway in
136. Kefas, B., Godlewski, J., Comeau, L., Li, Y., Abounader, R., Hawkinson, M., Lee, J., Fine, H., Chiocca, E.A., Lawler, S., and Purow, B. (2008) microRNA-7 inhibits EGFR and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 68(10), 3566-3572.
137. Wang, Z., Li, Y., Kong, D., Ahmad, A., Banerjee, S., and Sarkar, F.H. (2010) Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett. 292(2), 141-148.
138. DeSano, J.T. and Xu, L. (2009) MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J. 11, 682-692.
139. Kefas, B., Comeau, L., Floyd, D.H., Seleverstov, O., Godlewski, J., Schmittgen, T., Jiang, J., di Pierro, C.G., Li, Y., Chiocca, E.A., Lee, J., Fine, H., Abounader, R., Lawler, S., and Purow, B. (2009) The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J. Neurosci. 29(48), 15161-15168.
140. Li, Y., Guessous, F., Zhang, Y., DiPierro, C., Kefas, B., Johnson, E., Marcinkiewicz, L., Jiang, J., Yang, Y., Schmittgen, T.D., Lopes, B., Schiff, D., Purow, B., and Abounader, R. (2009) MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 69(19), 7569-7576.
141. Liau, L.M., Black, K.L., Prins, R.M., Sykes, S.N., DiPatre, P.L., Cloughesy, T.F., Becker, D.P., and Bronstein, J.M. (1999) Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J. Neurosurg. 90(6), 1115-1124. (Pubitemid 29241181)
142. Hatano, M., Eguchi, J., Tatsumi, T., Kuwashima, N., Dusak, J.E., Kinch, M.S., Pollack, I.F., Hamilton, R.L., Storkus, W.J., and Okada, H. (2005) EphA2 as a glioma-associated antigen: a novel target for glioma vaccines. Neoplasia 7(8), 717-722.
143. Ehtesham, M., Samoto, K., Kabos, P., Acosta, F.L., Gutierrez, M.A., Black, K.L., and Yu, J.S. (2002) Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer. Cancer Gene Ther. 9, 925-934. (Pubitemid 35278565)
144. Haynes, N.M., van der Most, R.G., Lake, R.A., and Smyth, M.J. (2008) Immunogenic anti-cancer chemotherapy as an emerging concept. Curr. Opin. Immunol. 20(5), 545-557.
145. Dudley, M.E., Wunderlich, J.R., Robbins, P.F., Yang, J.C., Hwu, P., Schwartzentruber, D.J., Topalian, S.L., Sherry, R., Restifo, N.P., Hubicki, A.M., Robinson, M.R., Raffeld, M., Duray, P., Seipp, C.A., Rogers-Freezer, L., and Morton, K.E. (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850-854. (Pubitemid 35231542)
146. Okada, H., Lieberman, F.S., Walter, K.A., Lunsford, L.D., Kondziolka, D.S., Bejjani, G.K., Hamilton, R.L., Torres-Trejo, A., Kalinski, P., Cai, Q., Mabold, J.L., Edington, H.D., Butterfield, L.H., Whiteside, T.L., Potter, D.M., Schold, S.C., Jr.,and Pollack, I.F. (2007) Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas J. Transl. Med. 5, 67.
147. Akasaki, Y., Kikuchi, T., Homma, S., Abe, T., Kofe, D., and Ohno, T. (2001) Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. J. Immunother. 24, 106-113. (Pubitemid 32183056)
148. Heimberger, A.B., Crotty, L.E., Archer, G.E., Hess, K.R., Wikstrand, C.J., Friedman, A.H., Friedman, H.S., Bigner, D.D., and Sampson, J.H. (2003) Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors. Clin. Cancer Res. 9, 4247-4254. (Pubitemid 37204046)
149. Kikuchi, T., Akasaki, Y., Abe, T., and Ohno, T. (2002) Intratumoral injection of dendritic and irradiated glioma cells induces anti-tumor effects in a mouse brain tumor model. Cancer Immunol. Immunother. 51, 424-430. (Pubitemid 35013649)
150. Graf, M.R., Prins, R.M., Hawkins, W.T., and Merchant, R.E. (2002) Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination. Cancer Immunol. Immunother. 51, 179-189. (Pubitemid 34493952)
151. Maes, W. and Van Gool, S.W. (2010) Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model. Cancer Immunol. Immunother. [Epub ahead of print]
152. Elliott, L.H., Brooks, W.H., and Roszman, T.L. (1984) Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors. J. Immunol. 132(3), 1208-1215. (Pubitemid 14154539)
153. Ashkenazi, E., Deutsch, M., Tirosh, R., Weinreb, A., Tsukerman, A., and Brodie, C. (1997) A selective impairment of the IL-2 system in lymphocytes of patients with glioblastomas: increased level of soluble IL-2R and reduced protein tyrosine phosphorylation. Neuroimmunomodulation 4(1), 49-56. (Pubitemid 27397859)
154. Dix, A.R., Brooks, W.H., Roszman, T.L., and Morford, L.A. (1999) Immune defects observed in patients with primary malignant brain tumors. J. Neuroimmunol. 100(1-2), 216-232. (Pubitemid 30038255)
155. Sampson, J.H., Heimberger, A.B., Archer, G.E., Aldape, K.D., Friedman, A.H., Friedman, H.S., Gilbert, M.R., Herndon, J.E., II, McLendon, R.E., Mitchell, D.A., Reardon, D.A., Sawaya, R., Schmittling, R.J., Shi, W., Vredenburgh, J.J., and Bigner, D.D. (2010) Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J. Clin. Oncol. 28, 4722-4729.
156. Carpentier, A.F. and Meng, Y. (2006) Recent advances in immunotherapy for human glioma. Curr.Opinion Oncol. 18(6), 631-636. (Pubitemid 44427639)
157. Ransohoff, R.M., Kivisakk, P., and Kidd, G. (2003) Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3, 569-581. (Pubitemid 37328676)
158. Galea, I., Bernardes-Silva, M., Forse, P.A., van Rooijen, N., Liblau, R.S., and Perry, V.H. (2007) An antigen-specific pathway for CD8 T cells across the bloodbrain barrier. J. Exp. Med. 204(9), 2023-2030. (Pubitemid 47360864)
159. Galea, I., Bechmann, I., and Perry, V.H. (2007) What is immune privilege (not)? Trends Immunol. 28(1), 12-18. (Pubitemid 44960159)
160. Liau, L.M., Prins, R.M., Kiertscher, S.M., Odesa, S.K., Kremen, T.J., Giovannone, A.J., Lin, J.W., Chute, D.J., Mischel, P.S., Cloughesy, T.F., and Roth, M.D. (2005) Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin. Cancer Res. 11(15), 5515-5525. (Pubitemid 41060828)
161. Nagai, T., Tanaka, M., Tsuneyoshi, Y., Xu, B., Michie, S.A., Hasui, K., Hirano, H., Arita, K., and Matsuyama, T. (2009) Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta. Cancer Immunol. Immunother. 58(10), 1577-1586.
162. Pollard, J.W. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78.
163. Kerber, M., Reiss, Y., Wickersheim, A., Jugold, M., Kiessling, F., Heil, M., Tchaikovski, V., Waltenberger, J., Shibuya, M., Plate, K.H., and Machein, M.R. (2008) Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res. 68(18), 7342-7351.
164. Barbera-Guillem, E., Nyhus, J.K., Wolford, C.C., Friece, C.R., and Sampsel, J.W. (2002) Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res. 62(23), 7042-7049. (Pubitemid 35424099)
165. Saio, M., Radoja, S., Marino, M., and Frey, A.B. (2001) Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J. Immunol. 167(10), 5583-5593. (Pubitemid 33062747)
166. Konur, A., Kreutz, M., Knuchel, R., Krause, S.W., and Andreesen, R. (1996) Three-dimensional co-culture of human monocytes and macrophages with tumor cells: analysis of macrophage differentiation and activation. Int. J. Cancer 66(5), 645-652. (Pubitemid 26197929)
167. Roggendorf, W., Strupp, S., and Paulus, W. (1996) Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol. 92(3), 288-293. (Pubitemid 26278960)
168. Qian, B.Z. and Pollard, J.W. (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1), 39-51.
169. Zou, J.P., Morford, L.A., Chougnet, C., Dix, A.R., Brooks, A.G., Torres, N., Shuman, J.D., Coligan, J.E., Brooks, W.H., Roszman, T.L., and Shearer, G.M. (1999) Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers. J. Immunol. 162, 4882-4892. (Pubitemid 29314893)
170. Zagzag, D., Salnikow, K., Chiriboga, L., Yee, H., Lan, L., Ali, M.A., Garcia, R., Demaria, S., and Newcomb, E.W. (2005) Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain. Lab. Invest. 85, 328-341. (Pubitemid 40333150)
171. Strege, R.J., Godt, C., Stark, A.M., Hugo, H.H., and Mehdorn, H.M. (2004) Protein expression of Fas, Fas ligand, Bcl-2 and TGFbeta2 and correlation with survival in initial and recurrent human gliomas. J. Neurooncol. 67, 29-39. (Pubitemid 38418246)
172. Wei, J., Barr, J., Kong, L.-Y., Wang, Y., Wu, A., Sharma, A.K., Gumin, J., Henry, V., Colman, H., Sawaya, R., Lang, F.F., and Heimberger, A.B. (2010) Glioma-associated cancer-initiating cells induce immunosuppression. Clin. Cancer Res. 16(2), 461-473.
173. Parsa, A.T., Waldron, J.S., Panner, A., Crane, C.A., Parney, I.F., Barry, J.J., Cachola, K.E., Murray, J.C., Tihan, T., Jensen, M.C., Mischel, P.S., Stokoe, D., and Pieper, R.O. (2007) Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat. Med. 13(1), 84-88. (Pubitemid 46067390)
174. Andaloussi, A.E. and Lesniak, M.S. (2006) An increase in CD4+CD25+FOXP3+ regulatory T cells in tumorinfiltrating lymphocytes of human glioblastoma multiforme. Neuro Oncol. 8(3), 234-243.
175. Jordan, J.T., Sun, W., Hussain, S.F., Deangulo, G., Prabhu, S.S., and Heimberger, A.B. (2008) Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy. Cancer Immunol. Immunother. 57(1), 123-131. (Pubitemid 350043644)
176. Grauer, O.M., Nierkens, S., Bennink, E., Toonen, L.W., Boon, L., Wesseling, P., Sutmuller, R.P., and Adema, G.J. (2007) CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Int. J. Cancer 121(1), 95-105. (Pubitemid 46753856)
177. Didenko, V.V., Ngo, H.N., Minchew, C., and Baskin, D.S. (2002) Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism. J. Neurosurg. 96(3), 580-584. (Pubitemid 34230215)
178. Okada, H., Kohanbash, G., Zhu, X., Kastenhuber, E.R., Hoji, A., Ueda, R., and Fujita, M. (2009) Immunotherapeutic approaches for glioma. Crit. Rev. Immunol. 29(1), 1-42.
179. Dunn, G.P., Dunn, I.F., and Curry, W.T. (2007) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun. 7, 12.
180. Gomez, G.G. and Kruse, C.A. (2006) Mechanisms of malignant glioma immune resistance and sources of immunosuppression. Gene Ther. Mol. Biol. 10(A), 133-146.
181. Waziri, A. (2010) Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg. Clin. N. Am. 21(1), 31-42.
182. Schwartzbaum, J.A., Huang, K., Lawler, S., Ding, B., Yu, J., and Chiocca, E.A. (2010) Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma. Neuro Oncol. 12(4), 320-327.
183. Sakaguchi, S. (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562.
184. Jiang, H. and Chess, L. (2006) Regulation of immune responses by T cells. N. Engl. J. Med. 354, 1166-1176.
185. + regulatory thymocytes. Blood 102(12), 4107-4114.
186. Wei, S., Kryczek, I., Zou, L., Daniel, B., Cheng, P., Mottram, P., Curiel, T., Lange, A., and Zou, W. (2005) Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res. 65(12), 5020-5026. (Pubitemid 40827308)
187. Motoyoshi, Y., Kaminoda, K., Saitoh, O., Hamasaki, K., Nakao, K., Ishii, N., Nagayama, Y., and Eguchi, K. (2006) Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide. Oncol. Rep. 16(1), 141-146.
188. Sharabi, A. and Ghera, N.H. (2010) Breaking tolerance in a mouse model of multiple myeloma by chemoimmunotherapy. Adv. Cancer Res. 107, 1-37.
189. Curiel, T.J., Barnett, B., Kryczek, I., Cheng, P., and Zou, W. (2006) Regulatory T cells in ovarian cancer: biology and therapeutic potential. Cancer Immunol. 6(Suppl 1), 20.
190. Fecci, P.E., Mitchell, D.A., Whitesides, J.F., Xie, W., Friedman, A.H., Archer, G.E., Herndon, J.E., Bigner, D.D., Dranoff, G., and Sampson, J.H. (2006) Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res. 66(6), 3294-3302.
191. El Andaloussi, A. and Lesniak, M.S. (2007) CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas. J. Neurooncol. 83(2), 145-152. (Pubitemid 46784987)
192. Heimberger, A.B., Kong, L.-Y., Abou-Ghazal, M., Reina-Ortiz, C., Yang, D.S., Wei, J., Qiao, W., Schmittling, R.J., Archer, G.E., Sampson, J.H., Hiraoka, N., Priebe, W., Fuller, G.N., and Sawaya, R. (2009) The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. Clin. Neurosurg. 56, 98-106.
193. Walker, L.S., Chodos, A., Eggena, M., Dooms, H., and Abbas, A.K. (2003) Antigendependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198, 249-258. (Pubitemid 36992178)
194. Liu, W., Putnam, A.L., Xu-Yu, Z., Szot, G.L., Lee, M.R., Zhu, S., Gottlieb, P.A., Kapranov, P., Gingeras, T.R., de St. Groth, B.F., Clayberger, C., Soper, D.M., Ziegler, S.F., and Bluestone, J.A. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD41 T reg cells. J. Exp. Med. 203(7), 1701-1711. (Pubitemid 44036276)
195. Banham, A.H. (2006) Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol. 27(12), 541-544.
196. Jacobs, J.F.M., Idema, A.J., Bol, K.F., Nierkens, S., Grauer, O.M., Wesseling, P., Grotenhuis, J.A., Hoogerbrugge, P.M., de Vries, I.J.M., and Adema, G.J. (2009) Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors. Neuro Oncol. 11(4), 394-402.
197. Heimberger, A.B., Abou-Ghazal, M., Reina-Ortiz, C., Yang, D.S., Sun, W., Qiao, W., Hiraoka, N., and Fuller, G.N. (2008) Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin. Cancer Res. 14(16), 5166-5172.
198. Dey, M., Hussain, S.F., and Heimberger, A.B. (2006) The role of glioma microenvironment in immune modulation: potential targets for intervention. Lett. Drug Des. Discov. 3(7), 443-451.
199. Marie, J.C., Letterio, J.J., Gavin, M., and Rudensky, A.Y. (2005) TGF-beta1 maintains suppressor function and Foxp3 expression in CD41+CD251 regulatory T cells. J. Exp. Med. 201, 1061-1067. (Pubitemid 40524674)
200. Peng, Y., Laouar, Y., Li, M.O., Green, E.A., and Flavell, R.A. (2004) TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. U. S. A. 101(13), 4572-4577. (Pubitemid 38437452)
201. Upender, M.B. and Naegele, J.R. (1999) Activation of microglia during developmentally regulated cell death in the cerebral cortex. Dev. Neurosci. 21, 491-505. (Pubitemid 30055172)
202. Badie, B. and Schartner, J. (2001) Role of microglia in glioma biology. Microsc. Res. Tech. 54(2), 106-113. (Pubitemid 32645875)
203. Kaur, G., Han, S.J., Yang, I., and Crane, C. (2010) Microglia and central nervous system immunity. Neurosurg. Clin. N. Am. 21(1), 43-51.
204. Giometto, B., Bozza, F., Faresin, F., Alessio, L., Mingrino, S., and Tavolato, B. (1996) Immune infiltrates and cytokines in gliomas. Acta Neurochir. 138(1), 50-56. (Pubitemid 26043363)
205. Graeber, M.B., Scheithauer, B.W., and Kreutzberg, G.W. (2002) Microglia in brain tumors. Glia 40(2), 252-259. (Pubitemid 35337382)
206. Hussain, S.F., Yang, D., Suki, D., Aldape, K., Grimm, E., and Heimberger, A.B. (2006) The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol. 8(3), 261-279. (Pubitemid 46542651)
207. Yang, I., Han, S.J., Kaur, G., Crane, C., and Parsa, A.T. (2010) The role of microglia in central nervous system immunity and glioma immunology J. Clin. Neurosci. 17, 6-10.
208. Nishie, A., Ono, M., Shono, T., Fukushi, J., Otsubo, M., Onoue, H., Ito, Y., Inamura, T., Ikezaki, K., Fukui, M., Iwaki, T., and Kuwano, M. (1999) Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin. Cancer Res. 5(5), 1107-1113. (Pubitemid 29233226)
209. Sliwa, M., Markovic, D., Gabrusiewicz, K., Synowitz, M., Glass, R., Zawadzka, M., Wesolowska, A., Kettenmann, H., and Kaminska, B. (2007) The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Brain 130(2), 476-489. (Pubitemid 46181101)
210. Ford, A.L., Goodsall, A.L., Hickey, W.F., and Sedgwick, J.D. (1995) Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 154(9), 4309-4321.
211. Markovic, D.S., Glass, R., Synowitz, M., Rooijen, N., and Kettenmann, H. (2005) Microglia stimulate the invasiveness of glioma cells by increasing the activity of metallo-protease-2. J. Neuropathol. Exp. Neurol. 64(9), 754-762. (Pubitemid 41285807)
212. Watters, J.J., Schartner, J.M, and Badie, B. (2005) Microglia function in brain tumors. J. Neurosci. Res. 81(3), 447-455. (Pubitemid 41359299)
213. Rodrigues, J.C., Gonzalez, G.C., Zhang, L., Ibrahim, G., Kelly, J.J., Gustafson, M., Dietz, A.B., Forsyth, P.A., Yong, V.W., and Parney, I.F. (2010) Normal human monocytes exposed to glioma cells acquire myeloid derived suppressor cell-like properties. Neuro Oncol. 12(4), 351-365.
214. Kostianovsky, A.M., Maier, L.M., Anderson, R.C., Bruce, J.N., and Anderson, D.E. (2008) Astrocytic regulation of human monocytic/microglial activation. J. Immunol. 181, 5425-5432.
215. Gustafson, M.P., Lin, Y., New, K.C., Bulur, P.A., O'Neill, B.P., Gastineau, D.A., and Dietz, A.B. (2010) Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol. 12(7), 631-644.
216. Kennedy, B.C., Maier, L.M., D'Amico, R., Mandigo, C.E., Fontana, E.J., Waziri, A., Assanah, M.C., Canoll, P., Anderson, R.C.E., Anderson, D.E., and Bruce, J.N (2009) Dynamics of central and peripheral immunomodulation in a murin glioma model BMC Immunol. 10, 11.
217. Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., and Heimberger, A.B. (2010) Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol. 12(11), 1113-1125.
218. Pollard, J.W. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78.
219. Parney, I.F., Waldron, J.S., and Parsa, A.T. (2009) Flow cytometry and in vitro analysis of human glioma-associated macrophages. J. Neurosurg. 110, 572-582.
220. Hussain, S.F., Yang, D., Suki, D., Grimm, E., and Heimberger, A.B. (2006) Innate immune functions of microglia isolated from human glioma patients. J. Transl. Med. 4, 15.
221. Savage, N.D., de Boer, T., Walburg, K.V., Joosten, S.A., van Meijgaarden, K., Geluk, A., and Ottenhoff, T.H. (2008) Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J. Immunol. 181, 2220-2226.
222. Almand, B., Clark, J.I., Nikitina, E., van Beynen, J., Nicholas R. English, N.R., Knight, S.C., Carbone, D.P., and Gabrilovich, D.I. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678-689. (Pubitemid 32038493)
223. Gabrilovich, D.I. and Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9(3), 162-174.
224. Ostrand-Rosenberg, S. and Sinha, P. (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182, 4499-4506.
225. Lekkou, A., Karakantza, M., Mouzaki, A., Kalfarentzos, F., and Gogos, C.A. (2004) Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired sever infections. Clin. Diagn. Lab. Immunol. 11, 161-167. (Pubitemid 38090671)
226. Haveman, J.W., van den Berg, A.P., Verhoeven, E.L.G., Nijsten, M.W.N., van den Dungen, J.J.A.M., The, T.H., and Zwaveling, J.H. (2006) HLA-DR expression on monocytes and systemic inflammation in patients with ruptured abdominal aortic aneurysms. Crit. Care 10, R119.
227. Ho, Y.-P., Sheen, I.S., Chiu, C.-T., Wu, C.-S., and Lin, C.-Y. (2006) A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am. J. Gastroenterol. 101(5), 1117-1124. (Pubitemid 43725329)
228. Cavaillon, J.M., Adrie, C., Fitting, C., and Adib-Conquy, M. (2005) Reprogramming of circulatory cells in sepsis and SIRS. J. Endotoxin Res. 11(5), 311-320. (Pubitemid 41556040)
229. Kim, O.Y., Monsel, A., Bertrand, M., Coriat, P., Cavaillon, J.-M., and Adib-Conquy, M. (2010) Differential downregulation of HLA-DR on monocyte subpopulations during systemic inflammation. Crit. Care 14, R61.
230. Antoniades, C.G., Berry, P.A., Davies, E.T., Hussain, M., Bernal, W., Vergani, D., and Wendon, J. (2006) Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44, 34-43. (Pubitemid 44049137)
231. Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., and Rivoltini, L. (2007) Identification of a new subset of myeloid suppressor cells in pheripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25, 2546-2553. (Pubitemid 47041228)
232. Hoechst, B., Ormandy, L.A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M.P., Greten, T.F., and Korangy, F. (2008) A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+ CD25+ Foxp3+ T cells. Gastroenterology 135, 234-243. (Pubitemid 351899008)
233. Ko, J.S., Zea, A.H., Rini, B.I., Ireland, J.L., Elson, P., Cohen, P., Golshayan, A., Rayman, P.A., Wood, L., Garcia, J., Dreicer, R., Bukowski, R., and Finke, J.H. (2009) Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin. Cancer Res. 15, 2148.
234. Schartner, J.M., Hagar, A.R., Van Handel, M., Zhang, L., Nadkarni, N., and Badie, B. (2005) Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 51, 279-285. (Pubitemid 41532103)
235. Levy, D.E. and Lee, C. (2002) What does Stat3 do? J. Clin. Invest. 109(9), 1143-1148. (Pubitemid 34496591)
236. Yu, H., Kortylewski, M., and Pardoll, D. (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 7, 41-51. (Pubitemid 46020826)
237. Huang, S. (2007) Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin. Cancer Res. 13(5), 1362-1366.
238. Yu, H. and Jove, R. (2004) The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer 4(2), 97-105. (Pubitemid 38198738)
239. Hodge, D.R., Hurt, E.M., and Farrar, W.L. (2005) The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41, 2502-2512. (Pubitemid 41540626)
240. Abou-Ghazal, M., Yang, D.S., Qiao, W., Reina-Ortiz, C., Wei, J., Kong, L.-Y., Fuller, G.N., Hiraoka, N., Priebe, W., Sawaya, R., and Heimberger, A.B. (2008) The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated-STAT3 expression in human gliomas. Clin. Cancer Res. 14(24), 8228-8235.
241. Wei, J., Barr, J., Kong, L.Y., Wang, Y., Wu, A., Sharma, A.K., Gumin, J., Henry, V., Colman, H., Priebe, W., Sawaya, R., Lang, F.F., and Heimberger, A.B. (2010) Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway. Mol. Cancer Ther. 9(1), 67-78.
242. Sherry, M.M., Reeves, A., Wu, J.K., and Cochran, B.H. (2009) STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells 27(10), 2383-2392.
243. Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mule, J., Kerr, W.G., Jove, R., Pardoll, D., and Yu, H. (2005) Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat. Med. 11(12), 1314-1321. (Pubitemid 41752912)
244. Kinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K., Takaki, H., Himeno, K., Takaesu, G., Kobayashi, T., and Yoshimura, A. (2006) Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med. 203, 1021-1031.
245. Zorn, E., Nelson, E.A., Mohseni, M., Porcheray, F., Kim, H., Litsa, D., Bellucci, R., Raderschall, E., Canning, C., Soiffer, R.J., Frank, D.A., and Ritz, J. (2006) IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108, 1571-1579. (Pubitemid 44316124)
246. Shnaper, S., Desbaillets, I., Brown, D.A., Murat, A., Migliavacca, E., Schluep, M., Ostermann, S., Hamou, M.-F., Stupp, R., Breit, S.N., de Tribolet, N., and Hegi, M.E. (2009) Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastomaand worse outcome. Int. J. Cancer 125, 2624-2630.
247. El Kasmi, K.C., Smith, A.M., Williams, L., Neale, G., Panopoulos, A.D., Watowich, S.S., Hacker, H., Foxwell, B.M., and Murray, P.J. (2007) Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated antiinflammatory signaling pathway. J. Immunol. 179, 7215-7219.
248. Nishinakamura, H., Minoda, Y., Saeki, K., Koga, N., Takaesu, G., Onodera, M., Yoshimura, A., and Kobayashi, T. (2007 An RNA-binding protein αCP-1 is involved in the STAT3-mediated suppression of NF-κB transcriptional activity. Int. Immunol. 19, 609-619. (Pubitemid 47072204)
249. Linos, E., Raine, T., Alonso, A., and Michaud, D. (2007) Atopy and risk of brain tumors: a meta-analysis. J. Natl. Cancer Inst. 99(20), 1544-1550. (Pubitemid 351767237)
250. Steiner, G.E., Newman, M.E., Paikl, D., Stix, U., Memaran-Dagda, N., Lee, C., and Marberger, M.J. (2003) Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 56(3), 171-182. (Pubitemid 36918167)
251. Honorati, M.C., Cattini, L., and Facchini, A. (2007) Possible prognostic role of IL-17R in osteosarcoma. J. Cancer Res. Clin. Oncol. 133(12), 1017-1021. (Pubitemid 47561720)
252. Wainwright, D.A., Sengupta, S., Han, Y., Ulasov, I.V., and Lesniak, M.S. (2010) The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma. PLoS One 5(10), e15390.
253. Nam, J.S., Terabe, M., Kang, M.J., Chae, H., Voong, N., Yang, Y., Laurence, A., Michalowska, A., Mamura, M., Lonning, S., Berzofsky, J.A., and Wakefield L.M. (2008) Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res. 68(10), 3915-3923.